Leverage and the art of the possible
Loan houses are scrambling to win the mandate for a deal backing the buyout of French healthcare group Sebia and some are said to be offering financing equivalent to six times the firm’s Ebitda. That scares many bankers, who think the market isn’t ready for such leverage. But, with the right margin, investors may have different ideas.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
